PROP1 and cardiofaciocutaneous syndrome: Unifying features include GH deficiency, with the evolution of other pituitary abnormalities such as TSH deficiency, which parallels the phenotype of both murine models (Prop1:Cre;BrafV600E) and the human CFC-causing mutation (CAG:Cre;BrafQ241R/+).